Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b14585b37785a42767c9d030f8fde91 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2000-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f1afa6b3da7c28e0cd3de1d0295814 |
publicationDate |
2001-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1126279-A1 |
titleOfInvention |
Analytical method to evaluate animal models of neurofibrillary degeneration |
abstract |
The present invention relates to methods for modeling aspects of Alzheimer's diseasen(AD), in particular the present invention relates to methods for modeling abnormal taunhyperphosphorylation as the key step to the process of neurofibrillary degeneration and taunaggregation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1876185-A1 |
priorityDate |
2000-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |